Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 220Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 11Vytorin

02 4Zocor

PharmaCompass

01

Brand Name : Vytorin

Ezetimibe, Simvastatin

arrow
CPhI Korea
Not Confirmed

Brand Name : Vytorin

arrow
CPhI Korea
Not Confirmed

Ezetimibe, Simvastatin

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 183

2019 Revenue in Millions : 285

Growth (%) : -36

blank

02

Brand Name : Zocor

Ezetimibe, Simvastatin

arrow
CPhI Korea
Not Confirmed

Brand Name : Zocor

arrow
CPhI Korea
Not Confirmed

Ezetimibe, Simvastatin

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 65

2020 Revenue in Millions : 77

Growth (%) : -16

blank

03

Brand Name : Vytorin

Ezetimibe, Simvastatin

arrow
CPhI Korea
Not Confirmed

Brand Name : Vytorin

arrow
CPhI Korea
Not Confirmed

Ezetimibe, Simvastatin

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 164

2020 Revenue in Millions : 182

Growth (%) : -10

blank

04

Brand Name : Vytorin

Ezetimibe, Simvastatin

arrow
CPhI Korea
Not Confirmed

Brand Name : Vytorin

arrow
CPhI Korea
Not Confirmed

Ezetimibe, Simvastatin

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 130

2021 Revenue in Millions : 164

Growth (%) : -21

blank

05

Brand Name : Vytorin

Ezetimibe, Simvastatin

arrow
CPhI Korea
Not Confirmed

Brand Name : Vytorin

arrow
CPhI Korea
Not Confirmed

Ezetimibe, Simvastatin

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 129

2022 Revenue in Millions : 130

Growth (%) : -1

blank

06

Brand Name : Vytorin

Ezetimibe, Simvastatin

arrow
CPhI Korea
Not Confirmed

Brand Name : Vytorin

arrow
CPhI Korea
Not Confirmed

Ezetimibe, Simvastatin

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2024 Revenue in Millions : 108

2023 Revenue in Millions : 129

Growth (%) : -16

blank

07

Brand Name : Vytorin

Ezetimibe, Simvastatin

arrow
CPhI Korea
Not Confirmed

Brand Name : Vytorin

arrow
CPhI Korea
Not Confirmed

Ezetimibe, Simvastatin

Main Therapeutic Indication : Cardiovascular

Currency : USD

2015 Revenue in Millions : 1,516

2014 Revenue in Millions : 1,251

Growth (%) : -17%

blank

08

Brand Name : Vytorin

Ezetimibe, Simvastatin

arrow
CPhI Korea
Not Confirmed

09

Brand Name : Zocor

Ezetimibe, Simvastatin

arrow
CPhI Korea
Not Confirmed

Brand Name : Zocor

arrow
CPhI Korea
Not Confirmed

Ezetimibe, Simvastatin

Main Therapeutic Indication : Antihypertensives

Currency : USD

2015 Revenue in Millions : 258

2014 Revenue in Millions : 217

Growth (%) : -16%

blank

10

Brand Name : Zocor

Ezetimibe, Simvastatin

arrow
CPhI Korea
Not Confirmed

Brand Name : Zocor

arrow
CPhI Korea
Not Confirmed

Ezetimibe, Simvastatin

Main Therapeutic Indication : Antihypertensives

Currency : USD

2014 Revenue in Millions : -14.30%

2013 Revenue in Millions :

Growth (%) :

blank